High plasma D-dimer level is associated with decreased survival in patients with lung cancer: A meta-analysis

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3701-3704

  Zhou, Yong Xin ^a   Yang, Zhong Min ^a   Feng, Jing ^a   Shan, Ying Jun ^a   Wang, Wei Li ^a   Mei, Yun Qing ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

D dimer; Lung cancer; Prognosis

Indexed keywords

D DIMER;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLISHING; STATISTICAL ANALYSIS; SURVIVAL TIME;

EID: 84891482328     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0953-2     Document Type: Article

References (15)

1. Kamikura Y, Wada H, Sase T, Yamaguchi M, Kaneko T, Sakaguchi A, et al. Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy. Thromb Res. 2006;117(6):671-9.
2. Kalweit GA, Feindt P, Micek M, Gams E, Hellstern P. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood. Thromb Res. 2000;97(3):105-11.
3. Lu WX, Li LY, Gao Y, et al. Thrombosis diseases and lung cancer. Chin J Tubere Respir Dis. 2000;23(7):400-2.
4. Zhang JX, Cui CB. The clinical analysis of 18 patients with lung cancer complicated with venous thromboembolism. Chin J Lung Cancer. 2006;9(6):550-1.
5. Komurcuoglu B, Ulusoy S, Gayaf M, Guler A, Ozden E. Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori. 2011;97(6):743-8.
6. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol (R Coll Radiol). 2007;19(7):494-8.
7. Buccheri G, Torchio P, Ferrigno D. Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer. 2003;97(12):3044-52.
8. Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yoshida M, Kobayashi H. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 1997;52(6):563-5.
9. Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116(24):5377-82.
10. Wang Z, Fu JK, Diao DM, et al. Plasma D-dimer level in the perioperative period in non-small-cell lung cancer. Thoracic Cancer. 2011;2:207-12.
11. Coskun F, Yilmaz D, Ursavas A, Uzaslan E, Ege E. Relationship between disease severity and D-dimer levels measured with two different methods in pulmonary embolism patients. Multidiscip Respir Med. 2010;5(3):168-72.
12. Beer JH, Haeberli A, Vogt A, et al. Coagulation markers predict survival in cancer patients. Thromb Haemost. 2002;88:745-9.
13. Buccheri G, Torchio P, Ferrigno P. Plasma levels of D-dimer in lung carcinoma- clinical and prognostic significance. Cancer. 2002;97:3044-52.
14. Unsul E, Atalav F, Atikcan S, Yilmaz A. Prognostic significance of hemostatic parameters in patients with lung cancer. Respir Med. 2004;98:93-8.
15. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S. Evaluating the prethrombotic state in lung cancer using molecular markers. Chest. 1993;103:196-200.